IBRX
IMMUNITYBIO (IBRX)
NASDAQ
$10.35+$1.07 (+11.48%)
Price as of Oct 02, 2026 6:02 PM EDT
  • $9.8B
    Market Cap
  • 271.20%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 39
Valuation
IBRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 77
Valuation
IBRX
vs History
vs S&P 500
3-Month Momentum
-10.11%
12-Month Momentum
217.34%
3-Month Risk Adjusted Momentum
-39.72%
12-Month Risk Adjusted Momentum
209.79%

True Yield

N/A
Valuation
IBRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
0.54%
Net Debt Paydown Yield
-2.24%

Financial Health Score

Score: 55
Valuation
IBRX
vs History
vs S&P 500
Ohlson's O-Score
-1